Elon Musk stated that Neuralink's Blindsight device 'will enable even those who have lost both eyes and their optic nerve to see,' positioning it as a groundbreaking advancement in vision restoration for the severely visually impaired.
With the FDA's Breakthrough Device designation, Neuralink's Blindsight implant is recognized as a medical device that promotes health equity, potentially addressing inequities in access to vision restoration technologies.
The FDA's Breakthrough Device Program allows Neuralink to collaborate with experts for expedited development and market launch of Blindsight, serving as a pivotal step toward making the device available to the public.
Despite the progress with Blindsight, Neuralink still faces significant challenges as it continues to advance its first brain implant device and conduct human trials.
Collection
[
|
...
]